Caribou Biosciences, Inc.

NASDAQ:CRBU

Biotechnology

Healthcare
$0.49 -2.74%

-$0.05 today

Market cap
$52.47M
Beta
2.33
P/E (TTM)
-1.1
EPS (TTM)
-$1.39
52W Low $1.20High $3.54

Volume 1.01M

Average 1.83M

Balance Sheet

Inspect the capital base behind the business.

Assets

$175.37M

FY 2025 · Annual

-44.0% YoY

Liabilities

$53.19M

FY 2025 · Annual

-11.9% YoY

Equity

$122.17M

FY 2025 · Annual

-51.7% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents240.42M58.34M51.16M16.29M12.36M
Short-term Investments135.41M189.33M277.67M193.24M126.98M
Net Receivables8.12M4.66M3.86M3.25M2.98M
Inventory00000
Other Current Assets671K1.12M1.22M1.78M2.91M
Total Current Assets391.19M260.25M338.84M219.38M145.23M
Property, Plant & Equipment (Net)4.89M34.91M40.45M39.29M24.43M
Goodwill00000
Intangible Assets00000
Long-term Investments45.3M77.07M51.33M49.13M3.55M
Tax Assets00000
Other Non-current Assets975K1.54M1.59M5.52M2.15M
Total Non-current Assets51.16M113.52M93.37M93.94M30.14M
Total Assets442.36M373.77M432.21M313.31M175.37M
Account Payables3.99M1.15M3.12M2.48M5.78M
Short-term Debt259K0000
Tax Payables00000
Deferred Revenue8.7M9.94M2.85M3.13M1.9M
Other Current Liabilities4.75M7.12M10.62M10.22M8.56M
Total Current Liabilities25.83M28.13M28.3M30.65M25.41M
Long-term Debt00000
Deferred Tax Liabilities476K381K557K548K4.27M
Deferred Revenue (Non-current)22.03M15.95M6.1M3.32M1.75M
Other Non-current Liabilities6.19M1.65M2.94M785K(4.27M)
Total Non-current Liabilities28.7M44.77M35.51M29.71M27.78M
Total Liabilities54.53M72.89M63.81M60.36M53.19M
Common Stock6K6K8K9K9K
Retained Earnings(97.79M)(197.22M)(299.29M)(448.39M)(596.52M)
Accumulated OCI(135K)(1.52M)30K255K103K
Other Stockholders Equity00000
Minority Interest00000
Total Equity387.83M300.87M368.4M252.95M122.18M
Total Debt259K27.75M27.11M26.49M27.23M
Net Debt(240.42M)(30.59M)(24.05M)10.19M14.87M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$12.1M
Short-term Investments$105.6M
Receivables$2.4M
Other Current$2.4M
Total Current Assets$122.4M
PP&E (Net)$23.5M
Long-term Investments$1.0M
Other Non-current$2.1M
Total Non-current Assets$26.6M
Total Assets$149.0M

Analysis

Selected assets total $149.0M for Latest. The largest visible component is Short-term Investments at $105.6M, about 70.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportOct 6, 2026
8-KCurrent reportAug 13, 2026
10-QQuarterly reportAug 13, 2026
SC 13GSC 13G filingJul 27, 2026
8-KCurrent reportJun 18, 2026

How much cash does CRBU have?

Caribou Biosciences, Inc. (CRBU) reported $12.36M in cash and equivalents in fiscal 2025.

How much debt does CRBU carry?

Caribou Biosciences, Inc. (CRBU) reported $27.23M of total debt, with net debt of $14.87M.